DK3526229T3 - Fremgangsmåde til at fremstille glucopyranosyl-substituerede benzyl-benzen-derivater. - Google Patents

Fremgangsmåde til at fremstille glucopyranosyl-substituerede benzyl-benzen-derivater. Download PDF

Info

Publication number
DK3526229T3
DK3526229T3 DK17777935.2T DK17777935T DK3526229T3 DK 3526229 T3 DK3526229 T3 DK 3526229T3 DK 17777935 T DK17777935 T DK 17777935T DK 3526229 T3 DK3526229 T3 DK 3526229T3
Authority
DK
Denmark
Prior art keywords
glucopyranosyl
preparing
substituted benzyl
benzene derivatives
benzene
Prior art date
Application number
DK17777935.2T
Other languages
English (en)
Inventor
Thomas Wirth
Alexander Berg
Bernd Meynhardt
Dirk Weber
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57136729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3526229(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK3526229T3 publication Critical patent/DK3526229T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK17777935.2T 2016-10-13 2017-10-09 Fremgangsmåde til at fremstille glucopyranosyl-substituerede benzyl-benzen-derivater. DK3526229T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16193735 2016-10-13
PCT/EP2017/075664 WO2018069243A1 (en) 2016-10-13 2017-10-09 Process for preparing glucopyranosyl-substituted benzyl-benzene derivatives

Publications (1)

Publication Number Publication Date
DK3526229T3 true DK3526229T3 (da) 2021-07-19

Family

ID=57136729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17777935.2T DK3526229T3 (da) 2016-10-13 2017-10-09 Fremgangsmåde til at fremstille glucopyranosyl-substituerede benzyl-benzen-derivater.

Country Status (11)

Country Link
US (3) US20190309004A1 (da)
EP (2) EP3526229B1 (da)
JP (1) JP2019530722A (da)
DK (1) DK3526229T3 (da)
ES (1) ES2878583T3 (da)
HR (1) HRP20211154T1 (da)
HU (1) HUE055463T2 (da)
PL (1) PL3526229T3 (da)
PT (1) PT3526229T (da)
SI (1) SI3526229T1 (da)
WO (1) WO2018069243A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339194B (es) 2009-02-13 2016-05-16 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de sglt2, un inhibidor de dpp-iv y opcionalmente otro agente antidiabetico, y usos de la misma.
KR20110118668A (ko) 2009-02-13 2011-10-31 베링거 인겔하임 인터내셔날 게엠베하 １형 당뇨병, ２형 당뇨병, 내당능 장애 또는 고혈당증을 치료하기 위한 ｓｇｌｔ­２ 억제제
US10610489B2 (en) 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
HRP20190101T1 (hr) 2013-04-05 2019-03-08 Boehringer Ingelheim International Gmbh Terapeutske uporabe empagliflozina
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
PL2986304T3 (pl) 2013-04-18 2022-05-02 Boehringer Ingelheim International Gmbh Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
WO2018087132A1 (en) 2016-11-10 2018-05-17 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011158B1 (ru) 2004-03-16 2009-02-27 Бёрингер Ингельхайм Интернациональ Гмбх Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
UA91546C2 (uk) 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
DK2486029T3 (da) * 2009-09-30 2015-08-24 Boehringer Ingelheim Int Fremgangsmåder til fremstilling af glucopyranosyl-substituerede benzyl-benzen-derivater.

Also Published As

Publication number Publication date
EP3526229B1 (en) 2021-04-28
US20190309004A1 (en) 2019-10-10
PT3526229T (pt) 2021-07-06
HRP20211154T1 (hr) 2021-10-15
US20250101055A1 (en) 2025-03-27
EP3889144A1 (en) 2021-10-06
US20230100086A1 (en) 2023-03-30
SI3526229T1 (sl) 2021-08-31
ES2878583T3 (es) 2021-11-19
JP2019530722A (ja) 2019-10-24
EP3526229A1 (en) 2019-08-21
WO2018069243A1 (en) 2018-04-19
HUE055463T2 (hu) 2021-11-29
PL3526229T3 (pl) 2021-11-02

Similar Documents

Publication Publication Date Title
IL261271A (en) Methods for making l-glufosinate
DOP2018000256A (es) 3-oxo-2,6-difenil-2,3-dihidropiridazin-4-carboxamidas
DK3294885T3 (da) Fremgangsmåde til at fremstille rna
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3072835T3 (da) Fremgangsmåde til fremføring
PL3325443T3 (pl) Sposób otrzymywania pridopidyny
DK3473621T3 (da) Fremgangsmåde til fremstilling af diphenylmethan-derivat
HUE049175T2 (hu) Eljárás anti-CD79b immunkonjugátumok alkalmazására
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
LT3168219T (lt) Piridono dariniai, turintys tetrahidropiranilmetilo grupę
IT201600117287A1 (it) Metodo di trasfezione transiente per produzione retrovirale.
DK3134084T3 (da) Fremgangsmåde til behandling af lungeadenokarcinom
EP3713931C0 (en) 3-OXO-6-HETEROARYL-2-PHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
HUE055463T2 (hu) Eljárás glükopiranozil-szubsztituált benzil-benzol-származékok elõállítására
FI20155728A7 (fi) Menetelmä kiinteän ligniinin valmistamiseksi
BR112017001387A2 (pt) alargador.
BR112017001386A2 (pt) alargador.
BR112017001389A2 (pt) alargador.
PT2992764T (pt) Método para preparar macarrão instantâneo não frito
LT3371168T (lt) Indolin-2-ono dariniai
BR112017001388A2 (pt) alargador.
DK3548473T3 (da) HMF-fremstillingsfremgangsmåde
DK3346990T3 (da) Fremgangsmåde til stråleformaling
LT3341380T (lt) Chromono oksimo darinys, prasiskverbiantis į smegenis, skirtas levadopa sukeltos diskinezijos gydymui